Drug Patent Expirations for the Week of June 26, 2022

By / June 26, 2022
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/
PRADAXA (dabigatran etexilate mesylate)
Boehringer ingelheimPatent: 6,087,380Expiration: Jun 28, 2022

See More …

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts

DrugPatentWatch - Make Better Decisions
Scroll to Top